HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Floeth, F. W. Articles by Langen, K.-J. Search for Related Content PubMed PubMed Citation Articles by Floeth, F. W. Articles by Langen, K.-J.

¹⁸F-FET PET Differentiation of Ring-Enhancing Brain Lesions

¹ Department of Neurosurgery, Heinrich-Heine-University, Düsseldorf, Germany; ² Institute of Medicine and Brain Imaging Center West, Research Center Jülich, Jülich, Germany; ³ Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany; and ⁴ Institute of Nuclear Chemistry and Brain Imaging Center West, Research Center Jülich, Jülich, Germany

Correspondence: For correspondence or reprints contact: Karl-Josef Langen, Institute of Medicine, Research Center Jülich, P.O. Box 1913, D-52425 Jülich, Germany. E-mail: k.j.langen{at}fz-juelich.de

The aim of this study was to explore the differential diagnostic value of PET using the amino acid O-(2-¹⁸F-fluoroethyl)-L-tyrosine (¹⁸F-FET) in patients with newly diagnosed solitary intracerebral lesions showing ring enhancement on contrast-enhanced MRI. Methods: ¹⁸F-FET PET analyses were performed on 14 consecutive patients with intracerebral ring-enhancing lesions. Eleven of the patients were additionally studied with ¹⁸F-FDG PET. In all patients, the main differential diagnosis after MRI was a malignant lesion, in particular glioblastoma multiforme, versus a benign lesion, in particular brain abscess. A malignant tumor was suspected for lesions showing increased ¹⁸F-FET uptake on PET images with a mean lesion-to-brain ratio of at least 1.6 (¹⁸F-FET PET positive). A nonneoplastic lesion was suspected in cases of minimal or absent ¹⁸F-FET uptake, with a mean lesion-to-brain ratio of less than 1.6 (¹⁸F-FET PET negative). Histologic diagnosis was obtained by serial biopsies in 13 of the 14 patients. One patient refused the biopsy, but follow-up indicated an abscess because his lesion regressed under antibiotic therapy. Results: Histology and clinical follow-up showed high-grade malignant gliomas in 5 patients and nonneoplastic lesions in 9 patients. The findings of ¹⁸F-FET PET were positive in all 5 glioma patients and in 3 of 9 patients with nonneoplastic lesions, including 2 patients with brain abscesses and 1 patient with a demyelinating lesion. The findings of ¹⁸F-FDG PET were positive (mean lesion-to-gray matter ratio 0.7) in 4 of 4 glioma patients and 3 of 7 patients with nonneoplastic lesions. Conclusion: Although ¹⁸F-FET PET has been shown to be valuable for the diagnostic evaluation of brain tumors, our data indicate that, like ¹⁸F-FDG PET, ¹⁸F-FET PET has limited specificity in distinguishing between neoplastic and nonneoplastic ring-enhancing intracerebral lesions. Thus, histologic investigation of biopsy specimens remains mandatory to make this important differential diagnosis.

Key Words: ring enhancement • ¹⁸F-FET PET • abscess • glioblastoma

This article has been cited by other articles:

				D. Riva, L. Chiapparini, B. Pollo, M. R. Balestrini, M. Massimino, and N. Milani A Case of Pediatric Tumefactive Demyelinating Lesion Misdiagnosed and Treated as Glioblastoma J Child Neurol, August 1, 2008; 23(8): 944 - 947. [Abstract] [PDF]

				C. Plathow and W. A. Weber Tumor Cell Metabolism Imaging J. Nucl. Med., June 1, 2008; 49(Suppl_2): 43S - 63S. [Abstract] [Full Text] [PDF]

				A. Stadlbauer, O. Prante, C. Nimsky, E. Salomonowitz, M. Buchfelder, T. Kuwert, R. Linke, and O. Ganslandt Metabolic Imaging of Cerebral Gliomas: Spatial Correlation of Changes in O-(2-18F-Fluoroethyl)-L-Tyrosine PET and Proton Magnetic Resonance Spectroscopic Imaging J. Nucl. Med., May 1, 2008; 49(5): 721 - 729. [Abstract] [Full Text] [PDF]

				F. W. Floeth, M. Sabel, G. Stoffels, D. Pauleit, K. Hamacher, H.-J. Steiger, and K.-J. Langen Prognostic Value of 18F-Fluoroethyl-L-Tyrosine PET and MRI in Small Nonspecific Incidental Brain Lesions J. Nucl. Med., May 1, 2008; 49(5): 730 - 737. [Abstract] [Full Text] [PDF]

				D. Salber, G. Stoffels, D. Pauleit, A.-M. Oros-Peusquens, N. J. Shah, P. Klauth, K. Hamacher, H. H. Coenen, and K.-J. Langen Differential Uptake of O-(2-18F-Fluoroethyl)-L-Tyrosine, L-3H-Methionine, and 3H-Deoxyglucose in Brain Abscesses J. Nucl. Med., December 1, 2007; 48(12): 2056 - 2062. [Abstract] [Full Text] [PDF]

				I. Rutten, J.-E. Cabay, N. Withofs, C. Lemaire, J. Aerts, V. Baart, and R. Hustinx PET/CT of Skull Base Meningiomas Using 2-18F-Fluoro-L-Tyrosine: Initial Report J. Nucl. Med., May 1, 2007; 48(5): 720 - 725. [Abstract] [Full Text] [PDF]

				N. Schiess and A. Nath Management of Brain Abscess Journal of Pharmacy Practice, April 1, 2007; 20(2): 158 - 166. [Abstract] [PDF]